ARSUF (Fagron) Accounts Payable & Accrued Expense : $177.8 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Fagron Accounts Payable & Accrued Expense?

Fagron's quarterly accounts payable & accrued expense increased from Dec. 2023 ($167.5 Mil) to Jun. 2024 ($202.9 Mil) but then declined from Jun. 2024 ($202.9 Mil) to Dec. 2024 ($177.8 Mil).

Fagron's annual accounts payable & accrued expense increased from Dec. 2022 ($150.6 Mil) to Dec. 2023 ($167.5 Mil) and increased from Dec. 2023 ($167.5 Mil) to Dec. 2024 ($177.8 Mil).

Fagron Accounts Payable & Accrued Expense Historical Data

The historical data trend for Fagron's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Accounts Payable & Accrued Expense Chart

Fagron Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

149.50

143.80

150.58

167.52

177.82

Fagron Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															150.58	205.54	167.52	202.90	177.82

Fagron Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Fagron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

FAGRb:UK 0HNZ:UK 4A5:Germany FAGR:Belgium

Address

Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB

Website

https://www.fagron.com

Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.